摘要
<strong>Background: </strong>Happy hypoxia is a new feature found in COVID-19 patients. It consists of the presence of severe hypoxemia but normal breathing rate. Failure to identify this hypoxia may have negative consequences on the survival of the patient. The objective of the present study was to measure the frequency of patients with happy hypoxia and to evaluate their survival at the Kinshasa University Hospital (KUH). <strong>Methods: </strong>This was a historical cohort of 141 hospitalized patients with COVID-19 at KUH from March 23 to June 15, 2020. Happy hypoxia was defined as oxygen saturation below 90% without dyspnea. Socio-demographic data, co-morbidities, follow up time of hospitalization and outcomes were studied. Survival was assessed using the Kaplan Meier curve. <strong>Results:</strong> Out of 141 hospitalized patients with COVID-19, 79 (56%) patients were at the severe or critical stage and 9 (6.4%) had a happy hypoxia on admission. Patients who had happy hypoxia on admission were generally older than 60 years of age (55.6%) (p = 0.023). Comparison of survival curves, based on the presence or absence of happy hypoxia, shows a statistically significant difference (p = 0.001). The presence of happy hypoxia reduces survival. <strong>Conclusion:</strong> The frequency of happy hypoxia among COVID-19 patients was low. Survival was reduced in patients with happy hypoxia. Prehospital pulse oximetry could serve as an early warning signal for the detection of happy hypoxemia in COVID-19 patients.
<strong>Background: </strong>Happy hypoxia is a new feature found in COVID-19 patients. It consists of the presence of severe hypoxemia but normal breathing rate. Failure to identify this hypoxia may have negative consequences on the survival of the patient. The objective of the present study was to measure the frequency of patients with happy hypoxia and to evaluate their survival at the Kinshasa University Hospital (KUH). <strong>Methods: </strong>This was a historical cohort of 141 hospitalized patients with COVID-19 at KUH from March 23 to June 15, 2020. Happy hypoxia was defined as oxygen saturation below 90% without dyspnea. Socio-demographic data, co-morbidities, follow up time of hospitalization and outcomes were studied. Survival was assessed using the Kaplan Meier curve. <strong>Results:</strong> Out of 141 hospitalized patients with COVID-19, 79 (56%) patients were at the severe or critical stage and 9 (6.4%) had a happy hypoxia on admission. Patients who had happy hypoxia on admission were generally older than 60 years of age (55.6%) (p = 0.023). Comparison of survival curves, based on the presence or absence of happy hypoxia, shows a statistically significant difference (p = 0.001). The presence of happy hypoxia reduces survival. <strong>Conclusion:</strong> The frequency of happy hypoxia among COVID-19 patients was low. Survival was reduced in patients with happy hypoxia. Prehospital pulse oximetry could serve as an early warning signal for the detection of happy hypoxemia in COVID-19 patients.
作者
Ben Bepouka
Hippolyte Situakibanza
Ossam Odio
Jean Robert Makulo
Madone Mandina
Murielle Longokolo
Nadine Mayasi
Kazadi Mutombo
Tresor Pata
Godelive Nsangana
Felly Tshikangu
Donatien Mangala
Dupont Maheshe
Christine Namasale
Serge Nkarnkwin
Jonathan Muamba
Gorby Ndaie
Rodrigue Ngwizani
Hervé Mole
Gabriel Makeya
Tharcisse Mabiala
Patrick Mukuna
Roger Kabango
Patricia Kabuni
Yves Yanga
Aliocha Nkodila
Hervé Keke
Nice Musangu
Papy Tshimanga
Yamin Kokusa
Bertin Nsitwayizatadi
Eric Mukenge
Guyguy Kamwiziku
Gabriel Mbunsu
Jean Claude Makangara
Marcel Mbula
Jean Marie Kayembe
Ben Bepouka;Hippolyte Situakibanza;Ossam Odio;Jean Robert Makulo;Madone Mandina;Murielle Longokolo;Nadine Mayasi;Kazadi Mutombo;Tresor Pata;Godelive Nsangana;Felly Tshikangu;Donatien Mangala;Dupont Maheshe;Christine Namasale;Serge Nkarnkwin;Jonathan Muamba;Gorby Ndaie;Rodrigue Ngwizani;Hervé Mole;Gabriel Makeya;Tharcisse Mabiala;Patrick Mukuna;Roger Kabango;Patricia Kabuni;Yves Yanga;Aliocha Nkodila;Hervé Keke;Nice Musangu;Papy Tshimanga;Yamin Kokusa;Bertin Nsitwayizatadi;Eric Mukenge;Guyguy Kamwiziku;Gabriel Mbunsu;Jean Claude Makangara;Marcel Mbula;Jean Marie Kayembe(Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo;Unit of Nephrology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo;Unit of Reanimation, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo;Unit of Vaccinology, World Health Organization, Kinshasa, Democratic Republic of the Congo;Department of Epidemiology, Ministry of Health, Kinshasa, Democratic Republic of the Congo;Unit of Physiotherapy, Kinshasa Hospital University, Kinshasa, Democratic Republic of the Congo;Unit of Microbiology, Kinshasa Hospital University, Kinshasa, Democratic Republic of the Congo;Unit of Pneumology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo)
